참고문헌 (40)

1. Agency E.M. Summary on Compassionate Use: Remdesivir Gilead 2020 https://www.ema.europa.eu/en/documents/other/summary-compassionate-use-remdesivir-gilead_en.pdf 

2. Aggarwal G. Cheruiyot I. Aggarwal S. Wong J. Lippi G. Lavie C.J. Henry B.M. Sanchis-Gomar F. Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) severity: a meta-analysis Curr. Probl. Cardiol. 45 2020 100617 32402515 

   상세보기

3. Aggarwal G. Henry B.M. Aggarwal S. Bangalore S. Cardiovascular safety of potential drugs for the treatment of coronavirus disease 2019 Am. J. Cardiol. 128 2020 147 150 32425199 

   상세보기

4. Bansal M. Cardiovascular disease and COVID-19 Diabetes Metabol. Syndr. 14 2020 247 250 

5. Bojkova D. Wagner J.U.G. Shumliakivska M. Aslan G.S. Saleem U. Hansen A. Luxan G. Gunther S. Pham M.D. Krishnan J. Harter P.N. Ermel U.H. Frangakis A.S. Milting H. Zeiher A.M. Klingel K. Cinatl J. Dendorfer A. Eschenhagen T. Tschope C. Ciesek S. Dimmeler S. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes Cardiovasc. Res. 2020 

6. Borba M.G.S. Val F.F.A. Sampaio V.S. Alexandre M.A.A. Melo G.C. Brito M. Mourao M.P.G. Brito-Sousa J.D. Baia-da-Silva D. Guerra M.V.F. Hajjar L.A. Pinto R.C. Balieiro A.A.S. Pacheco A.G.F. Santos J.D.O. Jr. Naveca F.G. Xavier M.S. Siqueira A.M. Schwarzbold A. Croda J. Nogueira M.L. Romero G.A.S. Bassat Q. Fontes C.J. Albuquerque B.C. Daniel-Ribeiro C.T. Monteiro W.M. Lacerda M.V.G. CloroCovid T. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial JAMA Net. Open 3 2020 e208857 

7. Burridge P.W. Holmstrom A. Wu J.C. Chemically defined culture and cardiomyocyte differentiation of human pluripotent stem cells Curr. Protoc. Human Genet. 87 2015 21 3 1 21 3 15 

8. Burridge P.W. Li Y.F. Matsa E. Wu H. Ong S.G. Sharma A. Holmstrom A. Chang A.C. Coronado M.J. Ebert A.D. Knowles J.W. Telli M.L. Witteles R.M. Blau H.M. Bernstein D. Altman R.B. Wu J.C. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity Nat. Med. 22 2016 547 556 27089514 

   상세보기

9. Choy K.T. Wong A.Y. Kaewpreedee P. Sia S.F. Chen D. Hui K.P.Y. Chu D.K.W. Chan M.C.W. Cheung P.P. Huang X. Peiris M. Yen H.L. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro Antivir. Res. 178 2020 104786 32251767 

   상세보기

10. Eastman R.T. Roth J.S. Brimacombe K.R. Simeonov A. Shen M. Patnaik S. Hall M.D. Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19 ACS Cent. Sci. 6 2020 672 683 32483554 

11. Geleris J. Sun Y. Platt J. Zucker J. Baldwin M. Hripcsak G. Labella A. Manson D.K. Kubin C. Barr R.G. Sobieszczyk M.E. Schluger N.W. Observational study of hydroxychloroquine in hospitalized patients with covid-19 N. Engl. J. Med. 382 2020 2411 2418 32379955 

    상세보기

12. Gintant G. Sager P.T. Stockbridge N. Evolution of strategies to improve preclinical cardiac safety testing Nat. Rev. Drug Discov. 15 2016 457 471 26893184 

13. Gintant G. Burridge P. Gepstein L. Harding S. Herron T. Hong C. Jalife J. Wu J.C. Use of human induced pluripotent stem cell-derived cardiomyocytes in preclinical cancer drug cardiotoxicity testing: a scientific statement from the American heart association Circ. Res. 125 2019 e75 e92 31533542 

14. Goineau S. Castagne V. Proarrhythmic risk assessment using conventional and new in vitro assays Regul. Toxicol. Pharmacol. 88 2017 1 11 28506844 

    상세보기

15. Goineau S. Castagne V. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers J. Pharmacol. Toxicol. Methods 90 2018 58 66 29274391 

    상세보기

16. Guan W.J. Ni Z.Y. Hu Y. Liang W.H. Ou C.Q. He J.X. Liu L. Shan H. Lei C.L. Hui D.S.C. Du B. Li L.J. Zeng G. Yuen K.Y. Chen R.C. Tang C.L. Wang T. Chen P.Y. Xiang J. Li S.Y. Wang J.L. Liang Z.J. Peng Y.X. Wei L. Liu Y. Hu Y.H. Peng P. Wang J.M. Liu J.Y. Chen Z. Li G. Zheng Z.J. Qiu S.Q. Luo J. Ye C.J. Zhu S.Y. Zhong N.S. China Medical Treatment Expert Group for C. Clinical characteristics of coronavirus disease 2019 in China N. Engl. J. Med. 382 2020 1708 1720 32109013 

    상세보기

17. Jakhar D. Kaur I. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus Nat. Med. 26 2020 632 

    상세보기

18. Ko M. Jeon S. Ryu W.S. Kim S. Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells J. Med. Virol. 2020 10.1002/jmv.26397 

    상세보기

19. Ladipo G.O. Essien E.E. Andy J.J. Complete heart block in chronic chloroquine poisoning Int. J. Cardiol. 4 1983 198 200 6629533 

    상세보기

20. Laflamme M.A. Chen K.Y. Naumova A.V. Muskheli V. Fugate J.A. Dupras S.K. Reinecke H. Xu C. Hassanipour M. Police S. O'Sullivan C. Collins L. Chen Y. Minami E. Gill E.A. Ueno S. Yuan C. Gold J. Murry C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts Nat. Biotechnol. 25 2007 1015 1024 17721512 

    상세보기

21. Lan F. Lee A.S. Liang P. Sanchez-Freire V. Nguyen P.K. Wang L. Han L. Yen M. Wang Y. Sun N. Abilez O.J. Hu S. Ebert A.D. Navarrete E.G. Simmons C.S. Wheeler M. Pruitt B. Lewis R. Yamaguchi Y. Ashley E.A. Bers D.M. Robbins R.C. Longaker M.T. Wu J.C. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells Cell Stem Cell 12 2013 101 113 23290139 

    상세보기

22. Livak K.J. Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408 11846609 

23. Long B. Brady W.J. Koyfman A. Gottlieb M. Cardiovascular complications in COVID-19 Am. J. Emerg. Med. 38 2020 1504 1507 32317203 

24. Madjid M. Safavi-Naeini P. Solomon S.D. Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review JAMA Cardiol. 5 2020 831 840 32219363 

    상세보기

25. Millard D. Dang Q. Shi H. Zhang X. Strock C. Kraushaar U. Zeng H. Levesque P. Lu H.R. Guillon J.M. Wu J.C. Li Y. Luerman G. Anson B. Guo L. Clements M. Abassi Y.A. Ross J. Pierson J. Gintant G. Cross-site reliability of human induced pluripotent stem cell-derived cardiomyocyte based safety assays using microelectrode arrays: results from a blinded CiPA pilot study Toxicol. Sci. 164 2018 550 562 29718449 

    상세보기

26. Mitcheson J.S. Hancox J.C. Levi A.J. Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties Cardiovasc. Res. 39 1998 280 300 9798514 

    상세보기

27. Moreno L. Pearson A.D. How can attrition rates be reduced in cancer drug discovery? Expet Opin. Drug Discov. 8 2013 363 368 

28. Mumtaz N. Jimmerson L.C. Bushman L.R. Kiser J.J. Aron G. Reusken C. Koopmans M.P.G. van Kampen J.J.A. Cell-line dependent antiviral activity of sofosbuvir against Zika virus Antivir. Res. 146 2017 161 163 28912011 

    상세보기

29. Park S.J. Kim R.Y. Park B.W. Lee S. Choi S.W. Park J.H. Choi J.J. Kim S.W. Jang J. Cho D.W. Chung H.M. Moon S.H. Ban K. Park H.J. Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction Nat. Commun. 10 2019 3123 31311935 

    상세보기

30. Pruijssers A.J. George A.S. Schafer A. Leist S.R. Gralinksi L.E. Dinnon K.H. 3rd Yount B.L. Agostini M.L. Stevens L.J. Chappell J.D. Lu X. Hughes T.M. Gully K. Martinez D.R. Brown A.J. Graham R.L. Perry J.K. Du Pont V. Pitts J. Ma B. Babusis D. Murakami E. Feng J.Y. Bilello J.P. Porter D.P. Cihlar T. Baric R.S. Denison M.R. Sheahan T.P. Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice Cell Rep. 32 2020 107940 32668216 

    상세보기

31. Sala L. Bellin M. Mummery C.L. Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come? Br. J. Pharmacol. 174 2017 3749 3765 27641943 

    상세보기

32. Savarino A. Boelaert J.R. Cassone A. Majori G. Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect. Dis. 3 2003 722 727 14592603 

    상세보기

33. Sharma A. Marceau C. Hamaguchi R. Burridge P.W. Rajarajan K. Churko J.M. Wu H. Sallam K.I. Matsa E. Sturzu A.C. Che Y. Ebert A. Diecke S. Liang P. Red-Horse K. Carette J.E. Wu S.M. Wu J.C. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform Circ. Res. 115 2014 556 566 25015077 

    상세보기

34. Sharma A. Burridge P.W. McKeithan W.L. Serrano R. Shukla P. Sayed N. Churko J.M. Kitani T. Wu H. Holmstrom A. Matsa E. Zhang Y. Kumar A. Fan A.C. Del Alamo J.C. Wu S.M. Moslehi J.J. Mercola M. Wu J.C. High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells Sci. Transl. Med. 9 2017 

    상세보기

35. Sharma A. Garcia G. Arumugaswami V. Svendsen C.N. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection 2020 bioRxiv 

36. Shi S. Qin M. Shen B. Cai Y. Liu T. Yang F. Gong W. Liu X. Liang J. Zhao Q. Huang H. Yang B. Huang C. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in wuhan, China JAMA Cardiol. 5 7 2020 802 810 32211816 

    상세보기

37. Shin J.S. Jung E. Kim M. Baric R.S. Go Y.Y. Saracatinib inhibits Middle East respiratory syndrome-coronavirus replication in vitro Viruses 10 2018 

    상세보기

38. Sun N. Yazawa M. Liu J. Han L. Sanchez-Freire V. Abilez O.J. Navarrete E.G. Hu S. Wang L. Lee A. Pavlovic A. Lin S. Chen R. Hajjar R.J. Snyder M.P. Dolmetsch R.E. Butte M.J. Ashley E.A. Longaker M.T. Robbins R.C. Wu J.C. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy Sci. Transl. Med. 4 2012 130ra47 

39. Tay M.Z. Poh C.M. Renia L. MacAry P.A. Ng L.F.P. The trinity of COVID-19: immunity, inflammation and intervention Nat. Rev. Immunol. 20 2020 363 374 32346093 

    상세보기

40. Traebert M. Dumotier B. Meister L. Hoffmann P. Dominguez-Estevez M. Suter W. Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells Eur. J. Pharmacol. 484 2004 41 48 14729380 

    상세보기

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.